Monitor completion of the acquisition by December 31, 2026, and any subsequent integration updates. The activist stake from the August 2026 SC 13D/A adds pressure to execute the acquisition programme successfully. Watch for additional acquisition announcements as part of the planned programme.
Price Chart
Executive Summary
Davion Healthcare Plc announced a $13.5 million agreement to acquire Healthcare Stat Homecare Inc. (HSH), a profitable US home healthcare provider, with $8 million in cash and $5.5 million in stock. HSH reported $11.6 million in gross receipts and $1.9 million in ordinary business income for 2025. The acquisition is the first in a planned programme of acquisitions and would add an established revenue stream and expand Davion into care delivery, but the deal is subject to completion conditions and the stock component will dilute existing shareholders.
Key Facts
- Davion agreed to acquire Healthcare Stat Homecare Inc. for $13.5 million total consideration ($8M cash + $5.5M in shares at $13/share).
- HSH reported unaudited gross receipts of approximately $11.6 million and ordinary business income of approximately $1.9 million for the year ended December 31, 2025.
- Completion expected on or before December 31, 2026, subject to the acquisition agreement terms.
- The acquisition is described as the first in a planned programme of acquisitions of profitable healthcare businesses over the coming year.
- Davion's market cap is $75 million; the deal value represents approximately 18% of market cap.
- A prior SC 13D/A was filed on August 11, 2026, indicating activist stake context.
Financial Impact
Deal value of $13.5 million (18% of $75M market cap); HSH contributed $11.6M revenue and $1.9M income in 2025. Cash consideration of $8M and stock issuance of $5.5M (approximately 423,077 shares at $13/share) will dilute existing shareholders by roughly 5-6% based on current market cap.
Risk Factors
- Completion risk: the acquisition is subject to terms of the agreement and may not close by the expected date.
- Integration risk: combining a home healthcare services business with a technology developer may face operational challenges.
- Dilution: the $5.5 million stock component will dilute existing shareholders; exact share count not disclosed.
- Cash consideration of $8 million may strain Davion's balance sheet given its $75 million market cap.
- Forward-looking statements about the acquisition programme are aspirational and not guaranteed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001683168-26-008146 |
| Document: davion_6k.htm | 0001683168-26-008146 |
| Document: 0001683168-26-008146-index-headers.html | 0001683168-26-008146 |
| Document: 0001683168-26-008146-index.html | 0001683168-26-008146 |
| Document: 0001683168-26-008146.txt | 0001683168-26-008146 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 3d ago | 6-K | $2.69 | awaiting T+20 | awaiting T+20 | $1.68 (−37.55%) |
Oct 29, 2026 3d ago | Press Release | $2.69 | awaiting T+20 | awaiting T+20 | $1.68 (−37.55%) |
Oct 27, 2026 5d ago | 6-K | $3.00 | awaiting T+20 | awaiting T+20 | $1.68 (−44.00%) |
Oct 26, 2026 6d ago | Press Release | $4.07 | awaiting T+20 | awaiting T+20 | $1.68 (−58.72%) |
Oct 20, 2026 12d ago | 6-K | No price | awaiting T+20 | awaiting T+20 | No price |
Sep 15, 2026 6w ago | 6-K | No price | awaiting T+20 | awaiting T+20 | No price |
Apr 30, 2026 26w ago | 20-F | No price | awaiting T+20 | awaiting T+20 | No price |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers